speb/financial-data huggingface dataset:
Financial scorecard for BOLD (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 2.57
Market cap: 57760172 (USD: 57760172)
P/B ratio: 0.28619351840061125
Debt to equity: 0.5589999999999999
Current ratio: 9.87
Return on net tangible assets (%): -15.372237593044927
Buffett classification: The Gruesome
Analyst consensus upside (%): 263.6363636363636
Rule of 40 score: 0
Altman Z-score: -1.693570989115753 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 1.2932786973002781
Total shareholder yield (%): 1.2932786973002781 (Low Return)
Momentum (%): 1m -1.1538461538461635, 3m 71.33333333333333, 6m 103.96825396825395, 12m 105.59999999999998, composite 94.43386243386243 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: 0.009562827778504776
FCF conversion rate: 1.1051272593139063
Beneish M-score: -2.4167004268364662 (Likely Safe)
ROE (%): -14.651123829288196
Asset turnover: 0
Equity multiplier (leverage): 1.6106454384798716
ROE archetype: Low Return
Treasury beta 1y: 0.015160348571108847 (R-squared: 0.004373873307526845)
Insider 90-day net shares: 590560 (net value USD: 1463389.00)
ROIC (%): -125.17722150194474 (pretax: -158.45217911638576)
Incremental ROIC 3y (%): -7.361032628260372 (pretax: -9.317762820582749)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 2.707581227436823, ROIC 27.256317689530686, revenue growth 1y , 6m momentum 2.436823104693141
Sector percentiles: P/E , 6m momentum 1.9340974212034383
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.058545872169401915
Base cash flow: -57492000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BONE.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.028368794326241138
Market cap: 9752827 (USD: 7016422.302158274)
P/B ratio: 1.0116331665292388
Debt to equity: 0.0141
Current ratio: 0.22
Interest coverage ratio: -55.028110699498804
Return on net tangible assets (%): -2.3118620900596887
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 7.118415889014878 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.0617977658896265
Total shareholder yield (%): 0.0617977658896265 (Low Return)
Momentum (%): 1m -19.43262411347517, 3m -2.8368794326241007, 6m -21.702127659574476, 12m -3.546099290780131, composite -1.606899077681214 (Moderate Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.009795997622865796
FCF conversion rate: 1.4345596560922718
Beneish M-score: -2.3905705337070975 (Likely Safe)
ROE (%): -2.369515121819234
Asset turnover: 0
Equity multiplier (leverage): 1.051139165284902
ROE archetype: Low Return
Treasury beta 1y: -0.00043596362193246884 (R-squared: 1.6656250499112598e-06)
Insider 90-day net shares: 240000 (net value USD: 8880.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 14.98751040799334, ROIC , revenue growth 1y , 6m momentum 35.13738551207327
Sector percentiles: P/E , 6m momentum 45.91893392559689
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BONLON.NS (Basic Materials — Other Industrial Metals & Mining, India)
Report date: 2026-03-31 (annual)
Stock price: 0.42237819983484726
Market cap: 670406976 (USD: 7104779.313268334)
P/E ratio: 0.21107359733652198
P/B ratio: 0.58926374165115
Debt to equity: 0.382
Current ratio: 2.5
Interest coverage ratio: 1.6171850054281884
Return on net tangible assets (%): -30.42057560900243
Buffett classification: The Gruesome
Rule of 40 score: -10.971586780242752
Altman Z-score: 5.179203098403393 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -4.326613373915373, 3m -20.052267927478923, 6m , 12m , composite -20.052267927478923 ()
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 6, recommendation: Neutral
Revenue growth 1y (%): -5.261487281605803
Net income growth 1y (%): -11.296159194976408
Revenue CAGR 3y (%): 3.5956334059445094
Net income CAGR 3y (%): 10.695973278142468
Revenue deceleration: yes
Revenue growth consistency score: 26.629919423840146
Accrual ratio: 0.2606473762241521
FCF conversion rate: -14.159133315563
Beneish M-score: -1.9656536846985455 (Likely Safe)
ROE (%): 2.7679007920323917
Net margin (%): 0.4032802976973664
Asset turnover: 4.263556083664895
Equity multiplier (leverage): 1.6097985607416
ROE archetype: Low Return
P/E z-score: 1.1449290881902467
Treasury beta 1y: -0.09835249371660693 (R-squared: 0.012158228630475117)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 3.0292267062429334 (pretax: 4.179850688375117)
Incremental ROIC 3y (%): 18.71893297168693 (pretax: 26.05472339621994)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 1.9150707743547042, P/B 9.075770191507077, ROIC 6.49458784346378, revenue growth 1y 7.49375520399667, 6m momentum 
Sector percentiles: P/E 11.410327595780121, 6m momentum 
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05080299930807166
Base cash flow: -3213416.7019923697
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BOR.L (Energy — Oil & Gas E&P, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0.0015999999999999999
Market cap: 108893000 (USD: 147152702.7027027)
P/B ratio: 0.0029608444802632686
Debt to equity: 0
Current ratio: 3.14
Return on net tangible assets (%): -0.46407763730082774
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 56.029813456342254 (Safe Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 1.3333333333333408, 3m 18.399999999999984, 6m 31.555555555555554, 12m 69.14285714285711, composite 38.9576162628794 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.003710106072019691
FCF conversion rate: 1.7678442682047584
Beneish M-score: -2.451279642233102 (Likely Safe)
ROE (%): -0.485090420662054
Asset turnover: 0
Equity multiplier (leverage): 1.003944070158694
ROE archetype: Low Return
Treasury beta 1y: 0.025746247222937488 (R-squared: 0.01584549352904559)
Insider 90-day net shares: 1500000 (net value USD: 184500.00)
ROIC (%): -0.4019103426084306 (pretax: -0.5087472691245957)
Incremental ROIC 3y (%): -0.9501522131090531 (pretax: -1.2027243203912061)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 0.6756756756756757, ROIC 38.73873873873874, revenue growth 1y , 6m momentum 21.62162162162162
Sector percentiles: P/E , 6m momentum 20.515361744301288
Industry median P/E: 11.260253542132737; industry median ROIC: 0.8337488598897688
Sector median P/E: 11.598358576086895; sector median ROIC: 4.629877910100043
WACC: 0.05
Base cash flow: -1867567.5675675676
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BRN.AX (Technology — Semiconductors, Australia)
Report date: 2025-12-31 (annual)
Stock price: 0.08333333333333333
Market cap: 290705440 (USD: 195104322.14765102)
P/B ratio: 13.417372570587348
Debt to equity: 0.026600000000000002
Current ratio: 11.4
Interest coverage ratio: -316.764759718052
Return on net tangible assets (%): -65.02269352833956
Buffett classification: The Gruesome
Analyst consensus upside (%): 934.235294117647
Rule of 40 score: -512.8438943955028
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0.5038701718137782
Debt paydown yield (%): 0.09170341203570742
Total shareholder yield (%): 0.5955735838494857 (Low Return)
Momentum (%): 1m -24.47916666666668, 3m -22.222222222222232, 6m -28.431372549019617, 12m -42.803030303030305, composite -24.972305885084793 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 5, short score 11, recommendation: Short
Revenue growth 1y (%): 412.33273391536727
Revenue CAGR 3y (%): -28.2333607784491
Revenue deceleration: no
Revenue growth consistency score: 260.7088213918189
Beneish M-score: -2.5492617400520827 (Likely Safe)
Equity multiplier (leverage): 1.1312045228482084
ROE archetype: Standard Business
Treasury beta 1y: 0.001294729641441363 (R-squared: 6.228941351342566e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 69.1358024691358, ROIC , revenue growth 1y 0, 6m momentum 78.39506172839506
Sector percentiles: P/E , 6m momentum 63.66366366366366
Industry median P/E: 31.956834532374103; industry median ROIC: 3.679818125534067
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.05955133392223412
Base cash flow: -13394671.812080536
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for BTTL.NS (Consumer Cyclical — Textile Manufacturing, India)
Report date: 2026-03-31 (annual)
Stock price: 0.5147605284888522
Market cap: 2911076608 (USD: 30850748.283170834)
Debt to equity: 0
Current ratio: 17.01
Interest coverage ratio: -8.129411764705884
Return on net tangible assets (%): -6.963308576971556
Buffett classification: The Gruesome
Rule of 40 score: 191.05952824814145
Altman Z-score: 140.74256482656864 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 14.500834544447203, 3m 42.90298919199377, 6m , 12m , composite 42.90298919199377 ()
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue growth 1y (%): 197.67642388877928
Net income growth 1y (%): -239.35695796239312
Revenue CAGR 3y (%): 24.15186898998791
FCF CAGR 3y (%): nan
Revenue deceleration: no
Revenue growth consistency score: 125.96482754865157
Beneish M-score: -2.7276311925102275 (Likely Safe)
ROE (%): -6.383653477961625
Net margin (%): -132.48666889925036
Asset turnover: 0.047814570270568214
Equity multiplier (leverage): 1.0077130123881108
ROE archetype: Low Return
Treasury beta 1y: -0.13922926046623504 (R-squared: 0.014193373072330246)
Insider 90-day net shares: 100000 (net value USD: 36660.00)
ROIC (%): -0.1102640271581564 (pretax: -0.13957471792171697)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC 73.64864864864865, revenue growth 1y 0.6756756756756757, 6m momentum 
Industry median P/E: 0.18251138762789332; industry median ROIC: 4.332358383927475
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.05
Base cash flow: -1189063.162356931
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CBLL (Healthcare — Medical Devices, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 16.91
Market cap: 641611072 (USD: 641611072)
P/B ratio: 4.939101439497773
Debt to equity: 0.15710000000000002
Current ratio: 10.44
Interest coverage ratio: -47.79953917050691
Return on net tangible assets (%): -13.935503114059072
Buffett classification: The Gruesome
Analyst consensus upside (%): 46.535733769776336
Rule of 40 score: -83.1056715619693
Altman Z-score: 9.236487148402642 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.024937225522192984
Total shareholder yield (%): 0.024937225522192984 (Low Return)
Momentum (%): 1m -9.134873723804402, 3m -20.16052880075543, 6m -24.2043926490363, 12m 9.94798439531859, composite -7.787873686558235 (Moderate Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 8, recommendation: Short
Revenue growth 1y (%): 29.295788394905074
Revenue deceleration: no
Accrual ratio: 0.002064828113758121
FCF conversion rate: 1.0195571768759184
Beneish M-score: -2.410637853826376 (Likely Safe)
ROE (%): -13.329101229448689
Net margin (%): -74.4961123273194
Asset turnover: 0.14172423846090065
Equity multiplier (leverage): 1.2624759833732344
ROE archetype: Low Return
Treasury beta 1y: 0.0022404580463882837 (R-squared: 0.00032338529239857105)
Insider 90-day net shares: -350789 (net value USD: -6946288.00)
ROIC (%): -251.4172524658057 (pretax: -318.2496866655768)
Incremental ROIC 3y (%): -11.42448502235662 (pretax: -14.461373446021039)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 48.96142433234421, ROIC 64.39169139465875, revenue growth 1y 13.649851632047477, 6m momentum 48.96142433234421
Sector percentiles: P/E , 6m momentum 53.796561604584525
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10099075221739438
Base cash flow: -52838000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CBRS (Technology — Semiconductors, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 199.12
Market cap: 44374003712 (USD: 44374003712)
Debt to equity: 0.4947
Current ratio: 2.51
Interest coverage ratio: -0.8597815188136577
Buffett classification: The Gruesome
Rule of 40 score: 27.537494708040796
Altman Z-score: 5.467167154831448 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.0004912786356058436
Total shareholder yield (%): 0.0004912786356058436 (Low Return)
Momentum (%): 1m 9.25052123340284, 3m , 6m , 12m , composite  ()
Lynch category: Speculative (confidence: Low)
Screener: long score 5, short score 7, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: 0.021346186568608948
FCF conversion rate: 8.541696415821791
Beneish M-score: 4.200126254872525 (Strong Manipulation Signal)
Net margin (%): -7.241760855402625
Asset turnover: 0.03908472634871467
ROE archetype: Standard Business
P/E z-score: 1.3326695761716125
Treasury beta 1y: 0.17680383766343738 (R-squared: 0.009496186070559244)
Insider 90-day net shares: -117547 (net value USD: -20676584.00)
Capital allocation category: Capital-Light Grower
Industry median P/E: 31.956834532374103; industry median ROIC: 3.679818125534067
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.06497209413436567
Base cash flow: -110458000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CBY.AX (Basic Materials — Other Precious Metals & Mining, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.034722222222222224
Market cap: 12866116 (USD: 8409226.14379085)
Current ratio: 3.43
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 25.868055555555546, 3m 62.037037037037045, 6m 68.9814814814815, 12m 162.1527777777778, composite 79.76479352916135 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.001530721974388496 (R-squared: 1.0755042079531636e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 2.292263610315186
Sector percentiles: P/E , 6m momentum 2.8872848417545804
Industry median P/E: 8.740359897172237; industry median ROIC: -12.638421644657798
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.10850000000000001
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CDNA (Healthcare — Diagnostics & Research, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 37.14
Market cap: 1918633088 (USD: 1918633088)
P/E ratio: 79.81564526165894
P/B ratio: 2.8603141281196676
Debt to equity: 0.0781
Current ratio: 3.4
Return on net tangible assets (%): 1.786832685599572
Buffett classification: The Gruesome
Analyst consensus upside (%): 103.91705069124424
Rule of 40 score: 0.7012622105006523
Altman Z-score: 10.164909496777623 (Safe Zone)
Piotroski F-score: 9 (Strong)
Magic formula: return on capital % 0.7350656571437916, earnings yield % 0.10239441934878846, rank 2795
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.08839626558134288
Total shareholder yield (%): 0.08839626558134288 (Low Return)
Momentum (%): 1m 36.896424622189464, 3m 74.9411210551107, 6m 81.88050930460332, 12m 189.25233644859813, composite 89.37148841689326 (Strong Uptrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 6, short score 5, recommendation: Neutral
Revenue growth 1y (%): 38.98565271299521
Revenue deceleration: no
Accrual ratio: 0.00556842858702641
FCF conversion rate: 0.18298326806692775
Beneish M-score: -2.505341614999829 (Likely Safe)
ROE (%): 0.9110723344079814
Net margin (%): 2.386576040781648
Asset turnover: 0.28557910444139806
Equity multiplier (leverage): 1.3367529628500445
ROE archetype: Low Return
FCF z-score: 3.8930837314165503
Treasury beta 1y: 0.004909313120941517 (R-squared: 0.0009198276944557374)
Insider 90-day net shares: -256656 (net value USD: -8287966.00)
ROIC (%): -13.022868489746001 (pretax: -16.484643657906332)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 44.11764705882353, P/B 44.11764705882353, ROIC 56.61764705882353, revenue growth 1y 5.88235294117647, 6m momentum 4.411764705882353
Sector percentiles: P/E 32.664756446991404, 6m momentum 3.116045845272206
Industry median P/E: 21.640734060420083; industry median ROIC: 2.9089897435686405
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.15
Base cash flow: -7526000
DCF price per share: base 1.4676979438107562, conservative 1.7202682897735702, aggressive 1.1493170560019472
Financial scorecard for CDR.AX (Basic Materials — Gold, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.020833333333333332
Market cap: 5168359 (USD: 3378012.4183006533)
Current ratio: 3.95
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 51.04166666666664, 3m -2.7777777777777843, 6m 1.3888888888888888, 12m 4.861111111111101, composite -10.654533844189016 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.0035396471074471882 (R-squared: 3.9625263418528975e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 10.906515580736544
Sector percentiles: P/E , 6m momentum 20.655191560244308
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.136
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CLNE (Energy — Oil & Gas Refining & Marketing, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 2.03
Market cap: 447056000 (USD: 447056000)
P/B ratio: 0.9689254094483859
Debt to equity: 0.5747
Current ratio: 2.46
Interest coverage ratio: -0.5078056481319067
Return on net tangible assets (%): -1.543845316400758
Buffett classification: The Gruesome
Analyst consensus upside (%): 95.16129032258064
Rule of 40 score: -18.79089027439401
Altman Z-score: -0.7844207904134957 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.37467341899001466
Total shareholder yield (%): 0.37467341899001466 (Low Return)
Momentum (%): 1m 17.341040462427735, 3m -10.964912280701755, 6m -12.500000000000004, 12m -6.018518518518533, composite -14.45743989603639 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Revenue growth 1y (%): 13.29170039705485
Revenue deceleration: no
Accrual ratio: 0.002886952683877248
FCF conversion rate: 1.2434740573638414
Beneish M-score: -2.3229894656808905 (Likely Safe)
ROE (%): -2.1992664386838423
Net margin (%): -10.558372180067373
Asset turnover: 0.11230265046521304
Equity multiplier (leverage): 1.8547734642167373
ROE archetype: Low Return
FCF z-score: 2.8552994943252417
Treasury beta 1y: 0.0032398656762662333 (R-squared: 0.0007165891798256513)
Insider 90-day net shares: -126000 (net value USD: -269104.00)
ROIC (%): -10.274660034115707 (pretax: -13.005898777361654)
Incremental ROIC 3y (%): -50.294738829818144 (pretax: -63.6642263668584)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 28.57142857142857, ROIC 89.6103896103896, revenue growth 1y 23.376623376623375, 6m momentum 70.12987012987013
Sector percentiles: P/E , 6m momentum 59.26660059464817
Industry median P/E: 0.29649506720683355; industry median ROIC: 6.9416349763102385
Sector median P/E: 11.598358576086895; sector median ROIC: 4.629877910100043
WACC: 0.13939915164405803
Base cash flow: -178174000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CLON.L (Energy — Oil & Gas E&P, Ireland)
Report date: 2025-12-31 (annual)
Stock price: 0
Market cap: 1556731 (USD: 1831448.2352941176)
P/B ratio: 0
Debt to equity: 0
Current ratio: 0.28
Return on net tangible assets (%): -89.24026410605616
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Beneish M-score: -2.4499123723410596 (Likely Safe)
Equity multiplier (leverage): 4.061330495918354
ROE archetype: Standard Business
Treasury beta 1y: 0.21367521367521397 (R-squared: 1.308615155299231e-06)
Insider 90-day net shares: 0 (net value USD: 0.00)
Incremental ROIC 3y (%): 22.0065801925294 (pretax: 27.85643062345494)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 65.76576576576578, ROIC , revenue growth 1y , 6m momentum 
Industry median P/E: 11.260253542132737; industry median ROIC: 0.8337488598897688
Sector median P/E: 11.598358576086895; sector median ROIC: 4.629877910100043
WACC: 0.06945000000000001
Base cash flow: -304503.5294117647
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CNDT (Technology — Information Technology Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 1.48
Market cap: 229543296 (USD: 229543296)
P/B ratio: 0.3097097065834633
Debt to equity: 1.1506999999999998
Current ratio: 1.59
Interest coverage ratio: -0.3333333333333333
Buffett classification: The Gruesome
Analyst consensus upside (%): 290.62499999999994
Rule of 40 score: -9.146773005694168
Altman Z-score: -0.9718698505160598 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -16.554611117895597
Total shareholder yield (%): -16.554611117895597 (Minimal or Negative)
Momentum (%): 1m 11.278195488721797, 3m -12.941176470588234, 6m -12.426035502958579, 12m -46.37681159420289, composite -25.726268725481788 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 15, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -3.7283621837549963
Revenue deceleration: no
Accrual ratio: -0.004592901878914405
FCF conversion rate: 0.6666666666666666
Beneish M-score: -2.482031116211587 (Likely Safe)
ROE (%): -4.97737556561086
Net margin (%): -4.564315352697095
Asset turnover: 0.3018789144050104
Equity multiplier (leverage): 3.61236802413273
ROE archetype: Low Return
Treasury beta 1y: 0.00473822173936035 (R-squared: 0.0009467871150359371)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -3.5436968290796593 (pretax: -4.4856921887084305)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 3.821656050955414, ROIC 72.1868365180467, revenue growth 1y 39.27813163481954, 6m momentum 40.552016985138
Sector percentiles: P/E , 6m momentum 45.412078745412074
Industry median P/E: 0.21619799348899724; industry median ROIC: 12.533738935242045
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.06641685957282105
Base cash flow: -35000000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CRGO (Industrials — Integrated Freight & Logistics, Spain)
Report date: 2026-03-31 (quarterly)
Stock price: 1.23
Market cap: 65121204 (USD: 65121204)
P/B ratio: 1.9689740186478693
Debt to equity: 0.0613
Current ratio: 1.85
Interest coverage ratio: -77.68852459016394
Return on net tangible assets (%): -33.984563434635795
Buffett classification: The Gruesome
Analyst consensus upside (%): 70.73170731707317
Rule of 40 score: -83.01566842467187
Altman Z-score: -3.765914206294687 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.2326550589021703
Total shareholder yield (%): 0.2326550589021703 (Low Return)
Momentum (%): 1m -10.8695652173913, 3m -40.29126213592234, 6m -47.43589743589743, 12m -51.764705882352935, composite -44.53650417099875 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 8.959890105343282
Revenue deceleration: no
Revenue growth consistency score: 12.732711498455698
Accrual ratio: -0.0325931727092643
FCF conversion rate: 0.6933911159263272
Beneish M-score: -2.383012506232166 (Likely Safe)
ROE (%): -15.877827592497667
Net margin (%): -90.28787031861376
Asset turnover: 0.1177368722400279
Equity multiplier (leverage): 1.493651152980918
ROE archetype: Low Return
Treasury beta 1y: -0.00553511412539906 (R-squared: 0.0008219249801180679)
Insider 90-day net shares: -13834 (net value USD: -20465.00)
ROIC (%): -86.96764553761281 (pretax: -110.08562726280103)
Incremental ROIC 3y (%): 117.67415019519004 (pretax: 148.95462050024045)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 55.1948051948052, ROIC 87.66233766233766, revenue growth 1y 18.181818181818183, 6m momentum 82.46753246753246
Sector percentiles: P/E , 6m momentum 82.53968253968253
Industry median P/E: 1.6524312026398307; industry median ROIC: 5.860649403527186
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.11011880621069857
Base cash flow: -16677647.058823528
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CRL (Healthcare — Diagnostics & Research, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 226.58
Market cap: 10913844224 (USD: 10913844224)
P/B ratio: 2.780476283776164
Debt to equity: 1.0255
Current ratio: 1.36
Interest coverage ratio: 4.483471692468775
Buffett classification: The Good
Analyst consensus upside (%): 33.87246376811595
Rule of 40 score: -3.5755515972114984
Altman Z-score: 1.8710538084729345 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 5.393244376311235, earnings yield % 0.8666668941212173, rank 1356
Dividend yield (%): 0
Buyback yield (%): 1.9084476168532125
Debt paydown yield (%): -4.4515753572111825
Total shareholder yield (%): -2.5431277403579697 (Minimal or Negative)
Momentum (%): 1m 12.11281543790204, 3m 33.43934040047114, 6m 3.17380811438459, 12m 27.939017504234908, composite 16.909822326333426 (Moderate Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 1, short score 4, recommendation: Neutral
Revenue growth 1y (%): 1.184960291332371
Net income growth 1y (%): -157.1991653141665
Revenue deceleration: no
Accrual ratio: 3.901591109215626e-06
FCF conversion rate: 1.0019591947034185
Beneish M-score: -2.3704733086979557 (Likely Safe)
ROE (%): -0.4775218416561188
Net margin (%): -1.4863982808310656
Asset turnover: 0.1339766025617309
Equity multiplier (leverage): 2.3978890579525114
ROE archetype: Low Return
FCF z-score: 4.97570285394221
Treasury beta 1y: -0.003289136825489128 (R-squared: 0.0009629462637678545)
Insider 90-day net shares: -75000 (net value USD: -16875000.00)
ROIC (%): 5.691576901027187 (pretax: 7.204527722819224)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 43.38235294117647, ROIC 35.294117647058826, revenue growth 1y 44.85294117647059, 6m momentum 24.264705882352942
Sector percentiles: P/E , 6m momentum 24.964183381088827
Industry median P/E: 21.640734060420083; industry median ROIC: 2.9089897435686405
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10469296890781218
Base cash flow: 41997000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CTNM (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 14.06
Market cap: 525652448 (USD: 525652448)
P/B ratio: 1.7092150232161927
Debt to equity: 0.0278
Current ratio: 38
Return on net tangible assets (%): -5.873036821961199
Buffett classification: The Gruesome
Analyst consensus upside (%): 70.98009188361407
Rule of 40 score: 0
Altman Z-score: 27.780862761916833 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.2465507399292089
Total shareholder yield (%): 0.2465507399292089 (Low Return)
Momentum (%): 1m 9.672386895475821, 3m 13.295729250604355, 6m 8.237105465742882, 12m 146.66666666666666, composite 48.815038472700536 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.007888607801989253
FCF conversion rate: 1.1467902600996127
Beneish M-score: -2.2999978871610094 (Likely Safe)
ROE (%): -5.657593487662173
Asset turnover: 0
Equity multiplier (leverage): 1.0527581550985265
ROE archetype: Low Return
Treasury beta 1y: 0.0034987505692068523 (R-squared: 0.00037878729455666894)
Insider 90-day net shares: -126244 (net value USD: -1972168.00)
ROIC (%): -847.6526880025224 (pretax: -1072.9780860791425)
Incremental ROIC 3y (%): -25.412614849764093 (pretax: -32.16786689843556)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 19.494584837545126, ROIC 40.61371841155235, revenue growth 1y , 6m momentum 21.931407942238266
Sector percentiles: P/E , 6m momentum 21.131805157593124
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.08469756591870949
Base cash flow: -59886000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for CTW (Communication Services — Electronic Gaming & Multimedia, Japan)
Report date: 2026-01-31 (quarterly)
Stock price: 2.33
Market cap: 145392000 (USD: 145392000)
P/E ratio: 57.66666666666667
P/B ratio: 357.1689227525695
Debt to equity: 0.2002
Current ratio: 1.62
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.0015842722167411383
Total shareholder yield (%): -0.0015842722167411383 (Minimal or Negative)
Momentum (%): 1m -1.6877637130801704, 3m -15.272727272727272, 6m 45.625, 12m , composite 15.176136363636363 (Strong Uptrend)
Lynch category:  (confidence: Low)
Screener: long score 2, short score 3, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.4455409341248537 (Likely Safe)
Equity multiplier (leverage): 1.6728854589519642
ROE archetype: Standard Business
P/E z-score: 2.0695112510015283
Treasury beta 1y: 0.015945321922356853 (R-squared: 0.004177685705690659)
Insider 90-day net shares: -669 (net value USD: -1478.00)
ROIC (%): -4.134343829510585 (pretax: -4.7571751511243345)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 50.4, P/B 72.8, ROIC 58.4, revenue growth 1y , 6m momentum 5.6000000000000005
Sector percentiles: P/E 49.22701383238405, 6m momentum 4.231082180634662
Industry median P/E: 0.634833652550188; industry median ROIC: 5.123301786907901
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.05814114330620937
Base cash flow: 56292.09944381157
DCF price per share: base 0.09828041493164377, conservative 0.04986504218649837, aggressive 0.19692412782128751
Financial scorecard for CXAI (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 0.11
Market cap: 11923171 (USD: 11923171)
P/B ratio: 1.2314579604891815
Debt to equity: 0.6865000000000001
Current ratio: 2.29
Buffett classification: The Gruesome
Analyst consensus upside (%): 455.5555555555556
Rule of 40 score: -280.83448346894636
Altman Z-score: -3.6915724531953877 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 16.26245232916646
Total shareholder yield (%): 16.26245232916646 (High Return)
Momentum (%): 1m -38.888888888888886, 3m -31.25, 6m -60.71428571428572, 12m -89.90825688073394, composite -58.48350808213195 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 13, recommendation: Short
Revenue growth 1y (%): -22.38562091503268
Revenue deceleration: no
Accrual ratio: -0.05481252770432417
FCF conversion rate: 0.5520859355483387
Beneish M-score: -2.5340147023253836 (Likely Safe)
ROE (%): -26.751762622381126
Net margin (%): -421.3684210526316
Asset turnover: 0.02904177429955826
Equity multiplier (leverage): 2.1860861429478398
ROE archetype: Low Return
Treasury beta 1y: 0.013435754653244682 (R-squared: 0.0021212767116030123)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -77.31136623113028 (pretax: -97.86248890016492)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 19.00269541778976, ROIC 70.48517520215634, revenue growth 1y 53.908355795148246, 6m momentum 90.4312668463612
Sector percentiles: P/E , 6m momentum 81.71504838171505
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.08353420482438564
Base cash flow: -10333000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for DAR.L (Real Estate — Real Estate - Development, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0.10239999999999999
Market cap: 1381665920 (USD: 1381665920)
P/E ratio: 0.1742277992277992
P/B ratio: 0.022241671038388897
Debt to equity: 0.2955
Current ratio: 4.15
Interest coverage ratio: 3.933230851173841
Return on net tangible assets (%): 17.250363287660374
Buffett classification: The Great
Analyst consensus upside (%): 5947.091412742382
Rule of 40 score: 189.5049689007942
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 2.1100625498919303
Total shareholder yield (%): 2.1100625498919303 (Low Return)
Momentum (%): 1m -5.4386391251518855, 3m 1.4404283801873976, 6m 1.4404283801873976, 12m 12.260740740740717, composite 7.199401896083337 (Moderate Uptrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 7, short score 2, recommendation: Neutral
Revenue growth 1y (%): 142.28701446597896
Net income growth 1y (%): 630.6179139609402
Revenue CAGR 3y (%): 96.18962812682572
Revenue deceleration: no
Revenue growth consistency score: 204.46865530874808
Accrual ratio: -0.0904245782644351
FCF conversion rate: 2.523396608395847
Beneish M-score: -1.9584990082694627 (Likely Safe)
ROE (%): 19.628343913997103
Net margin (%): 18.712062256765996
Asset turnover: 0.31721364025247334
Equity multiplier (leverage): 3.306816920900267
ROE archetype: Leverage-Driven Returns
P/E z-score: 3.663801298757456
FCF z-score: 1.4734446487331216
Treasury beta 1y: 0.0033629423320517228 (R-squared: 0.001028628207369393)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 13.001359023220552 (pretax: 14.545482970801087)
Incremental ROIC 3y (%): 23.669649856496964 (pretax: 26.69833043564672)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 17.17557251908397, P/B 3.435114503816794, ROIC 8.778625954198473, revenue growth 1y 3.435114503816794, 6m momentum 22.519083969465647
Sector percentiles: P/E 12.655279503105591, 6m momentum 27.872670807453414
Industry median P/E: 0.7477477477477478; industry median ROIC: 1.4222722989118621
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.05
Base cash flow: 136215809.45945945
DCF price per share: base 1.1350902488231833, conservative 0.5376287084690239, aggressive 2.4534969474121127
Financial scorecard for DB.V (Healthcare — Drug Manufacturers - Specialty & Generic, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.07092198581560284
Market cap: 60589540 (USD: 43589597.12230216)
P/B ratio: 1.3394912599691597
Debt to equity: 0.9612999999999999
Current ratio: 2.76
Interest coverage ratio: 3.2371020856201977
Return on net tangible assets (%): -2.0557782231128927
Buffett classification: The Great
Analyst consensus upside (%): 168.07142857142856
Rule of 40 score: -35.80172426012711
Altman Z-score: 0.9883414377826846 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -21.748616776615037
Total shareholder yield (%): -21.748616776615037 (Minimal or Negative)
Momentum (%): 1m -16.075650118203303, 3m -25.259138025095464, 6m -18.439716312056728, 12m 7.171000788022093, composite -5.3331079402400805 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 8, recommendation: Short
Revenue growth 1y (%): 35.43269568802687
Revenue deceleration: no
Accrual ratio: 0.08834894544314698
FCF conversion rate: 6.721175930179145
Beneish M-score: -1.806777653945123 (Likely Safe)
ROE (%): -3.5234163253745607
Net margin (%): -5.230406996300033
Asset turnover: 0.2952436617611131
Equity multiplier (leverage): 2.2816440616945477
ROE archetype: Low Return
FCF z-score: 3.9759052804824493
Treasury beta 1y: 0.0016128731803273268 (R-squared: 6.4104669573842e-05)
Insider 90-day net shares: 1079500 (net value USD: 85849.00)
ROIC (%): 0.24015795746056115 (pretax: 0.30399741450703943)
Incremental ROIC 3y (%): 8.620860296425093 (pretax: 10.912481387879865)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 32.55131964809384, ROIC 59.530791788856305, revenue growth 1y 9.3841642228739, 6m momentum 59.530791788856305
Sector percentiles: P/E , 6m momentum 48.74641833810888
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.06320401438542521
Base cash flow: 1242335.766423358
DCF price per share: base 0.07000805088097455, conservative 0.021309367104993225, aggressive 0.1571750284558161
Financial scorecard for DBD (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 89.33
Market cap: 3093354240 (USD: 3093354240)
P/E ratio: 26.013793103448275
P/B ratio: 2.5456693553693235
Debt to equity: 1.0656999999999999
Current ratio: 1.28
Interest coverage ratio: 1.9141630901287554
Return on net tangible assets (%): -6.928838951310862
Buffett classification: The Great
Analyst consensus upside (%): 30.34199363732768
Rule of 40 score: -17.27332232546091
Altman Z-score: 1.0927970584354518 (Distress Zone)
Piotroski F-score: 4 (Weak)
Magic formula: return on capital % 6.472210129153969, earnings yield % 1.1639881451680414, rank 1006
Dividend yield (%): 0
Buyback yield (%): 1.9525730101962069
Debt paydown yield (%): -0.029094630946632224
Total shareholder yield (%): 1.9234783792495747 (Low Return)
Momentum (%): 1m 7.161708253358924, 3m 4.308734236338156, 6m 27.596057706041982, 12m 54.603669089650396, composite 25.392055373432125 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 2, short score 10, recommendation: Neutral
Revenue growth 1y (%): 6.027820710973719
Revenue deceleration: no
Accrual ratio: -0.003956118319170256
FCF conversion rate: 3.7636363636363637
Beneish M-score: -2.232422521998404 (Likely Safe)
ROE (%): 0.5161895823557016
Net margin (%): 0.6167302085669433
Asset turnover: 0.23210962612079175
Equity multiplier (leverage): 3.605959643359925
ROE archetype: Low Return
P/E z-score: 1.6828522605654619
FCF z-score: 3.1054593205214895
Treasury beta 1y: 0.0014827972276889193 (R-squared: 0.00034428161674322945)
Insider 90-day net shares: -1108958 (net value USD: -92312320.00)
ROIC (%): 11.875019524889419 (pretax: 14.708563787759072)
Incremental ROIC 3y (%): 44.68288589548975 (pretax: 55.707176111735436)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 44.20485175202156, P/B 37.06199460916442, ROIC 31.266846361185983, revenue growth 1y 36.52291105121294, 6m momentum 8.221024258760108
Sector percentiles: P/E 42.84284284284284, 6m momentum 15.949282615949285
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.09818511371918379
Base cash flow: 163300000
DCF price per share: base 53.99654955354492, conservative 44.209875130568, aggressive 65.97180826110494
Financial scorecard for DBG.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-05-31 (quarterly)
Stock price: 1.4539007092198581
Market cap: 482205120 (USD: 349424000)
P/B ratio: 13.565072189404447
Debt to equity: 0
Current ratio: 27.93
Return on net tangible assets (%): -10.20820372601105
Buffett classification: The Gruesome
Analyst consensus upside (%): 166.94208494208493
Rule of 40 score: 0
Altman Z-score: 431.73051654567263 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.0028514836175941066
Total shareholder yield (%): 0.0028514836175941066 (Low Return)
Momentum (%): 1m -17.41843971631206, 3m -25.118647683037377, 6m 40.30650200862967, 12m 235.13643466762835, composite 107.0042111697228 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.09643154490790605
FCF conversion rate: 0.12536281498404342
Beneish M-score: -3.02940303038013 (Likely Safe)
ROE (%): -11.17748350373905
Asset turnover: 0
Equity multiplier (leverage): 1.0138013153900116
ROE archetype: Low Return
Treasury beta 1y: 0.0020059712315119906 (R-squared: 7.223253979978824e-05)
Insider 90-day net shares: -1208700 (net value USD: -1856755.00)
ROIC (%): -11.791021033470283 (pretax: -14.925343080342133)
Incremental ROIC 3y (%): -12.842301305345929 (pretax: -16.25607760170371)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 54.87094088259784, ROIC 27.643630308076606, revenue growth 1y , 6m momentum 5.745212323064113
Sector percentiles: P/E , 6m momentum 5.469183786785119
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.12115000000000001
Base cash flow: -7332313.868613139
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for DBO.AX (Basic Materials — Gold, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.006944444444444445
Market cap: 6565948 (USD: 4291469.281045752)
Current ratio: 3.95
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 0.6944444444444402, 3m -2.77777777777778, 6m -66.20370370370371, 12m 4.861111111111119, composite -21.61451681566624 (Flat)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.001524569697462762 (R-squared: 3.6756627168242356e-06)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 78.04532577903683
Sector percentiles: P/E , 6m momentum 80.39977790116602
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.12335000000000002
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for DFIN (Technology — Software - Application, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 48.26
Market cap: 1205649408 (USD: 1205649408)
P/E ratio: 34.40875912408759
P/B ratio: 3.126278623573135
Debt to equity: 0.6257
Current ratio: 1.41
Interest coverage ratio: 16.4
Return on net tangible assets (%): -33.75742154368109
Buffett classification: The Great
Analyst consensus upside (%): 33.64446330080611
Rule of 40 score: 8.230191473606261
Altman Z-score: 3.093683966829387 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 55.218855218855225, earnings yield % 3.4764190482530126, rank 31
Dividend yield (%): 0
Buyback yield (%): 3.392362632835963
Debt paydown yield (%): -4.744331114870834
Total shareholder yield (%): -1.3519684820348705 (Minimal or Negative)
Momentum (%): 1m 18.110621634850705, 3m -4.416716181422071, 6m -11.07425833793994, 12m -23.3968253968254, composite -16.877943887406385 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 6, short score 5, recommendation: Neutral
Revenue growth 1y (%): 2.1879661859771193
Net income growth 1y (%): 8.064516129032251
Revenue deceleration: no
Accrual ratio: 0.06032171581769437
FCF conversion rate: -0.47761194029850745
Beneish M-score: -1.7888383116055606 (Likely Safe)
ROE (%): 8.86360629712925
Net margin (%): 16.30170316301703
Asset turnover: 0.2504265171825494
Equity multiplier (leverage): 2.171186664902765
ROE archetype: Standard Business
P/E z-score: 5.131806811283645
FCF z-score: 5.131806811283644
Treasury beta 1y: 0.0017230667574832897 (R-squared: 0.0002324719942874194)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): 21.35945819401486 (pretax: 28.413353338334584)
Incremental ROIC 3y (%): 6.36923638743932 (pretax: -5)
Capital allocation category: Fading Compounder
Industry percentiles: P/E 46.76549865229111, P/B 43.66576819407008, ROIC 19.946091644204852, revenue growth 1y 41.37466307277628, 6m momentum 36.79245283018868
Sector percentiles: P/E 45.111778445111774, 6m momentum 44.411077744411074
Industry median P/E: 2.1394954536591486; industry median ROIC: 6.21806735836372
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.08284486650453818
Base cash flow: 98500000
DCF price per share: base 61.05827364751887, conservative 53.150456341588566, aggressive 70.68442522921258